Although dialysis treatment prevents death from uremia, the morbidity and mortality remain much higher than in the normal population. More disquieting is the fact, that technological improvements such as high-flux membranes and computerised machines have not led to the expected improved outcome. While historical comparisons are difficult, due to changing age and risk factor profile, the large differences between countries and centres, even after accounting for these factors (1) , show that the results are often not as good as they could be, to say the least.
One of the causes of deterioration was short dialysis, which became popular for socio-economic reasons. Thus the concept of "adequate dialysis" emerged, resulting in a tremendous number of publications. Unfortunately discussions almost exclusively center around the narrow field of creatinine (KTN) and urea (URR) removal, stemming from the old "uremia tradition". Yet most patients die from cardiovascular complications. The factors mainly responsible for these, hypertension and fluid overload, are hardly ever mentioned and not incorporated in the "adequacy of dialysis" concept.
It is the purpose of this editorial to call for correction of this astonishing "inadequacy" and point to some deficiencies in our knowledge which remain to be investigated in the domain of cardiovascular and circulatory pathophysiology. Accordingly we may look from this angle at the chain of events responsible for most probems:
1. Excess salt inqestlon-sz. Extracellular fluid expansion-->3. Blood volume increase-sa. Hypertension-s 5. Cardiac dilatatton-se, Cardiac failure. 1) That "volume regulation" is governed by salt (NaCI) intake and excretion is well known. Yet textbooks stress (besides salt restriction) the need for water restriction which only leads to unbearable thirst. Some authors (2) blame "polydipsia" for what is in fact salt abuse! The advent of more frequent dialysis and peritoneal dialysis led to emphasize good nutrition with neglection of salt restriction, creating a feeling like "never mind, we will ultrafiltrate it off". Yet dialysis cannot be adequate without an adequate diet.
2) Because "salt means volume" all the ingested salt (in case of no residual function) has to be removed by ultrafil-0391-3988/008-03 $01.50/0 tration. The unnatural act of rapid removal of some liters of fluid (in case of HD) understandably may cause complaints. Because 3-5 L extracellular fluid excess often causes no visible edema or symptoms, the doctor (or nurse) is tempted to decrease UF or dialysis time. The vicious circle thus created was described by Charra (3) .
3) The reason that fluid excess is harmful is that it also increases blood volume. The relationship between extracellular and blood volume is steepest close to the normal value. This is also the range were "plasma refill" is slowest (4) . Thus while removal of large excesses is relatively well tolerated, problems can be expected when we approach normal value. Yet, it is the small excess that probably count most for the long-term development of hypertension In addition we should realize that the body is never in a steady state with the large fluctuations necessitated by excess salt intake. 4) Hypertension. While the exact mechanisms, in particular the role of "whole body autoregulation" are still not completely clear, the experience that good volume control can correct and prevent hypertension is overwhelming (3). Thus it is misleading to state that "lack of a comprehensive understanding of the pathophysiology of hypertension in dialysis patients has important influence on the poor result of control of blood pressure" (5) . Despite the fact that increased peripheral resistance is present in all forms (including volume-induced) hypertension this is often considered an argument for the use of vasodilating drugs. Yet their effect in slightly overhydrated patients has never been investigated, but data from many publications show that blood pressure of drug-consuming patients is higher than of not treated patients, casting doubts on their effectiveness.
Indeed the extreme divergence of hypotensive drug consumption (between 90% (6) and 3% (3) stronglly suggests that the proportion of drug prescriptions is inversely proportional to the attention given to volume control. Time is needed for full expression of the effect of changes in volume on blood pressure. It is interesting that both converting enzyme inhibition(CEI) and improved volume control have been shown to decrease the elevated sympathetic activity (7) which is often present in dialysis patients.
Next to increased volume, inappropriate renin secretion is classically considered to be responsible for hypertension resistant to volume control, Unfortunately this important and controversial subject has not attracted attention of investigators during the past decades. We (8) systematically tested all our hypertensive patients with a short captopril test" and found that blood pressure never dropped as long as they were overhydrated, thus making this test a simple tool to control "dry weight". However, some patients who needed CEI to control hypertension remained normotensive after some weeks or months of good volume control, despite stopping the drug. This "time factor" could explain the much lower need for drugs of the Tassin investigators. 5) Cardiac dilatation. When blood volume is increased, some degree of cardiac dilatation seems inevitable, starting with the most compliant part, the atria. Whether or not the even more compliant venous compartment can remain chronically expanded without affecting the heart is not known, but increased diameter of the left atria (right atrium is not systematically recorded) is present in nearly all dialysis patients. (9) . Cardiothoracic index on chest x ray is often reported to be increased above the upper limit of 0,50 in "uncomplicated" patients. While this may partly be due to left ventricular hypertrophy (LVH) and small pericardial effusions, there is no doubt that dilatation of the heart compartments is largely responsible. Cardiac dilatation is seldom mentioned as an independent risk factor and is never considered as a measure of adequate dialysis. Yet "strong dilatation" was recently found to have a risk ratio for mortality of 23! (10) There is no reason to believe that smaller degrees are innocent. Some consequences of cardiac dilatation have recently been pointed out:
Left ventricular hypertrophy is extremely frequent and traditionally attributed to hypertension. Yet it is well known that volume load also leads to hypertrophy, (11) which is logical as one considers that wall stress is proportional to the third power of the diameter (Laplace law). The fact that regression of LVH in dialysis patients (in contrast to essential hypertension) is very seldom reported may be due (apart from ineffective blood pressure control) to failure to correct volume load. Recently, we reported regression of LVH after a mean of 30 months of strict volume control alone in 15 patients (8) . Serious hypertension was also completely corrected without the use of drugs. In view of the difficulty to achieve such results with drugs alone, relief of volume load may be at least as important as of pressure load. This view is supported by a report of the same investigators showing a dramatic regression of LVH after 6 months volume reduction in a normotensive patient with extreme dilatation (13) .
Regurgitation through the mitral and tricuspid valves is not uncommon during dialysis treatment and can be completely or partly corrected by volume control (14) Thus relative, functional regurgitation can occur in patients with secondary heart failure. 6) Cardiac failure. Two forms of congestive failure can be distinguished: "left" and "right"sided failure. The first results in pulmonary edema and may occur after overhydration with a completely normal heart, as in acute glomerulonephritis. The clinical picture is indistinguishable from primary heart disease This was noticed 40 years ago by Eichna, who remarked that "it is hard to see how the heart, by improving any of its functions, could relieve the overfilling" (15) . Failure to realize the different pathophysiology of heart "failure" in renal patients may have dramatic consequences: A much quoted follow-up study reported de novo appearance of congestive failure in 25% of a large series of patients (16) .
The second form of congestion has been called uremic cardiomyopathy, but this concept is ill defined. Because the word "uremic" suggests some irreversible damage and invites therapeutic nihilism, I suggest the term "dilated cardiomyopathy of end stage renal disease". These are patients with extremely dilated hearts, severely disturbed diastolic and systolic functions (in particular low ejection fraction) but normal or low blood pressure. Edema may be extensive with ascites (wrongly called "dialysis ascites"). There is no doubt that the heart is damaged by long standing volume and pressure load, atherosclerosis, and maybe "toxic factors". However the question which the "metanephrolog" has to answer is to what extent functional factors can be corrected by adequate volume control. My personal experience with such relatively rare patients is that much can indeed be improved by slow but prolonged ultrafiltration (13) .
In conclusion, preoccupation with the "toxic effects" of renal failure has led to neglect the need to replace the other all-important kidney function: volume control. This resulted in an unacceptable high morbidity and mortality rate in many centres. Consequently, parameters of volume control: blood pressure and cardiac dimensions should be incorporated into the adequacy concept. But it is also necessary to ask how the disregard of many well-known and obvious principles came about: It takes much time and effort to convince and counsel the individual patient (3) . Apparently most doctors cannot afford this. One solution is to give better instruction and more responsability to the dialysis nurses, who have the longest and closest relationship with the patients. We have a successful experience of this approach in Turkey.
In contrast to the general belief there remains much to be investigated in the dialysis field.
